Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Episode 24: Comparing Outcomes of Anti-VEGF Agents for Treatment of DME

Moderators Thomas Albini, MD, and Jonathan L. Prenner, MD, discuss with Dante Pieramici, MD, a study comparing outcomes of anti-VEGF agents for DME. Dr. Pieramici analyzes data from phase 3 clinical trials of anti-VEGF agents. He explains similarities and differences found between agents, noting that most visual acuity gains for all the agents occurred during the first year of treatment.

37 / 60 Series: Retina Today Journal Club

More Videos in this Series